verified SJR 1,007 · Q1 • database Scopus / SJR & Web of Science indexed

United States · W.B. Saunders

workspace_premium Q1 — Oncology lock_open Open Access

Seminars in Radiation Oncology

Seminars in Radiation Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 107. It has an SJR impact factor of 1,007 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,007.

ISSN: 1053-4296

Publisher: W.B. Saunders

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,007 Q1

H-index 107

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,007

H-index

107

Docs (year)

Docs 3y

140

Total refs

3606

Cites 3y

455

Citable 3y

132

Cites/Doc 2y

3.02

Ref/Doc

70.71

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Considerations in genetic counseling for inherited breast cancer predisposition

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on radiation therapy oncology group 9406

Future strategies needed for palliative care

Functional imaging of normal tissues with nuclear medicine: Applications in radiotherapy

Farnesyltransferase inhibitors as radiation sensitizers

Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation therapy oncology group trial 98-01

Esophageal cancer and the esophagus: Challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment

Epidermal growth factor receptor modulation of radiation response: Preclinical and clinical development

Epidermal growth factor receptor as a therapeutic target in head and neck cancer

Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer

Dose-volume specification: New challenges with intensity-modulated radiation therapy

Developments in nuclear magnetic resonance imaging and spectroscopy: Application to radiation oncology*

SHOW MORE ARTICLES

Coronary artery radiation therapy for the prevention of restenosis after percutaneous coronary angioplasty, II: Outcomes of clinical trials

A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer

Computational Challenges for Image-Guided Radiation Therapy: Framework and Current Research

Clinical Management of Seizures in Patients With Low-Grade Glioma

Clinical aspects of intensity-modulated radiotherapy in the treatment of breast cancer

Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer

Chemotherapy options for gastric cancer

Chemotherapy of low-grade gliomas

Cancer Genesis Across the Age Spectrum: Associations With Tissue Development, Maintenance, and Senescence

Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes

Artifacts in computed tomography scanning of moving objects

Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma

FAQs

Seminars in Radiation Oncology has an SJR of 1,007 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Seminars in Radiation Oncology is 25%.

Seminars in Radiation Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Seminars in Radiation Oncology?

What is the APC / publication cost?

What is the acceptance rate?